Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Welphyllin
Welphyllin is a bronchodilator therapy formulated with Etophylline and Theophylline, designed to provide effective relief from respiratory conditions such as asthma, COPD, and other obstructive airway diseases. This combination works by relaxing the airway muscles, reducing inflammation, and improving breathing efficiency.
Uses of Welphyllin
Welphyllin is indicated for the treatment of:
Bronchial asthma
Chronic obstructive pulmonary disease (COPD)
Chronic bronchitis and emphysema
Exercise-induced bronchospasm
Respiratory distress syndromes
Benefits of Welphyllin
Dual-Action Bronchodilation: Enhances airway expansion and reduces breathlessness
Rapid Symptom Relief: Quickly alleviates bronchospasms and wheezing
Improves Pulmonary Function: Enhances oxygenation and respiratory efficiency
Mild Anti-Inflammatory Effect: Reduces airway hyperreactivity
Prolonged Action: Effective in both acute and maintenance therapy
Mechanism of Action of Welphyllin
Etophylline: A fast-acting bronchodilator that relaxes smooth muscles in the airways and improves lung function.
Theophylline: Inhibits phosphodiesterase (PDE) enzymes, increasing cyclic AMP levels, which leads to bronchodilation and reduced airway resistance. It also strengthens the diaphragm, improving breathing in patients with chronic respiratory conditions.